Proceedings of the Texas A&M Medical Student Grand Rounds

3D Silk Fibroin Biomaterials for Cartilage Repair and the Management of Osteoarthritis (OA)

May 30, 2024 Matthew Ho

Matthew Ho

Background: Osteoarthritis (OA) currently affects around 250 million people worldwide with an estimated cost of $303 billion a year, and its prevalence is only expected to increase by 50% in the next decade.1 Osteoarthritis occurs when an initial chronic or acute injury damages a joint and elevates proinflammatory cytokines.5 These proinflammatory cytokines, such as IL6,8, and TNF-α, contribute to joint degradation by inhibiting matrix synthesis and stimulating matrix-degrading enzymes such as matrix metalloproteinases (MMPs).5 In response to this damage, chondrocytes in the cartilage produce more inflammatory cytokines in a destructive cycle that must be interrupted for healing and repair.4 This is made more difficult by the lack of vascularization and blood flow in these areas.3 Current non-invasive therapies for cartilage repair focus on symptom relief rather than repairing or preventing deterioration.5 Tissue engineering, such as 3D scaffolds, has recently emerged as a potential solution to these problems, offering customizable properties including material and structure.5

Objective: In this review, we explore how the structure, material, and the addition of anti-inflammatory substances of a 3D bio-printed scaffold affect the healing of knee OA.

Search Methods: An online search in the PubMed database was conducted from 2019-2024 using the following keywords: “scaffolding”, “osteoarthritis”, “silk fibroin”, “anti-inflammatory”, “cartilage”, and “bioactive materials”.

Results: In a study, a macro-porous hydrogel scaffold was created by cross-linking silk fibroin (SF) and gelatin (GT) through extrusion-based printing. The gelatin provided adjustable thermosensitivity and gel kinetics and the covalent crosslinking with silk fibroin provided final stabilization.2 The addition of mesenchymal stem cells (MSC) using the cellular aggregate seeding method improved MSC retention and resulted in a higher collagen type II level, which has superior performance, than type I.2 Another study experimented with the addition of tannic acid (TA), which is a natural antioxidant that can bind to IL-1β by blocking its interaction with IL-1R, and inhibits the corresponding proinflammatory signaling cascade. When added to the SF scaffold in a rat OA model, the coating effectively downregulates the expression of proinflammatory molecules such as IL-6, IL-8, and MMPs. Additionally, it inhibits cartilage degeneration and delays OA development.8

Conclusion: Studies found the crosslinking of silk fibroin and gelatin had excellent structural stability, suitable mechanical properties, and an adjustable degradation rate in hydrogel.2 Additionally, another study showed that the addition of tannic acid effectively downregulated cytokines IL-6, IL-8, and MMPs. Thus, the use of 3d printed SF-GT scaffolds with tannic acid shows promise for patients who want to treat the underlying cause of OA with a less invasive treatment.2,8

Works Cited:

  1. Zhou Z, Cui J, Wu S, Geng Z, Su J. Silk fibroin-based biomaterials for cartilage/osteochondral repair. Theranostics. 2022;12(11):5103-5124. Published 2022 Jul 4. doi:10.7150/thno.74548
  2. Li Q, Xu S, Feng Q, et al. 3D printed silk-gelatin hydrogel scaffold with different porous structure and cell seeding strategy for cartilage regeneration. Bioact Mater. 2021;6(10):3396-3410. Published 2021 Mar 19. doi:10.1016/j.bioactmat.2021.03.013
  3. Zhou J, Li Q, Tian Z, Yao Q, Zhang M. Recent advances in 3D bioprinted cartilage-mimicking constructs for applications in tissue engineering. Mater Today Bio. 2023;23:100870. Published 2023 Nov 17. doi:10.1016/j.mtbio.2023.100870
  4.  Jang S, Lee K, Ju JH. Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee. Int J Mol Sci. 2021;22(5):2619. Published 2021 Mar 5. doi:10.3390/ijms22052619
  5.  Katz JN, Arant KR, Loeser RF. Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review. JAMA. 2021;325(6):568-578. doi:10.1001/jama.2020.22171
  6. Wu T, Chen Y, Liu W, et al. Ginsenoside Rb1/TGF-β1 loaded biodegradable silk fibroin-gelatin porous scaffolds for inflammation inhibition and cartilage regeneration. Mater Sci Eng C Mater Biol Appl. 2020;111:110757. doi:10.1016/j.msec.2020.110757
  7. Hasturk O, Jordan KE, Choi J, Kaplan DL. Enzymatically crosslinked silk and silk-gelatin hydrogels with tunable gelation kinetics, mechanical properties and bioactivity for cell culture and encapsulation. Biomaterials. 2020;232:119720. doi:10.1016/j.biomaterials.2019.119720
  8. Li Y, Chen M, Yan J, et al. Tannic acid/Sr2+-coated silk/graphene oxide-based meniscus scaffold with anti-inflammatory and anti-ROS functions for cartilage protection and delaying osteoarthritis. Acta Biomater. 2021;126:119-131. doi:10.1016/j.actbio.2021.02.046
  9. Yeo J, Lee J, Yoon S, Kim WJ. Tannic acid-based nanogel as an efficient anti-inflammatory agent. Biomater Sci. 2020;8(4):1148-1159. doi:10.1039/c9bm01384a
  10. Lee HR, Jeong YJ, Lee JW, et al. Tannic acid, an IL-1β-direct binding compound, ameliorates IL-1β-induced inflammation and cartilage degradation by hindering IL-1β-IL-1R1 interaction. PLoS One. 2023;18(4):e0281834. Published 2023 Apr 20. doi:10.1371/journal.pone.0281834
  11. Liu J, Han X, Zhang T, Tian K, Li Z, Luo F. Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy. J Hematol Oncol. 2023;16(1):116. Published 2023 Nov 30. doi:10.1186/s13045-023-01512-7
  12. Zhu S, Li Y, He Z, et al. Advanced injectable hydrogels for cartilage tissue engineering. Front Bioeng Biotechnol. 2022;10:954501. Published 2022 Sep 8. doi:10.3389/fbioe.2022.954501

 

Orthopedics
Previous Post

Donanemab: Antibody Therapy Targeting Removal of Amyloid-β via Microglial-Mediated Phagocytosis

Next Post

Stem Cell Therapy for Pulmonary Fibrosis

Scientific Editors

Steve A. Maxwell

Executive Editor
Tel: 979-436-0804
smaxwell@medicine.tamhsc.edu

Robin Fuchs-Young

Deputy Editor
Tel: 979-845-5109
fuchs-young@medicine.tamhsc.edu
Administrative Editor

Janis Chmiel

Tel: 979-436-0856
chmiel@medicine.tamhsc.edu
Editorial Office
Tel.: 979-845-2726
Fax: 979-847-9481
chmiel@medicine.tamhsc.edu
Archives
  • July 2026
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • May 2025
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • November 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • August 2022
  • June 2022
  • May 2022
  • August 2021
  • July 2021
  • April 2021
  • October 2020
  • August 2020
  • July 2020
  • August 2019
  • July 2019
  • February 2019
  • July 2018
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • January 2017
Proudly powered by WordPress | Theme: Fmi by Forrss.